Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs

American Journal of Gastroenterology

Volumn 110, Issue 5, 2015, Pages 749-759

  Masclee, Gwen M C ^a   Coloma, Preciosa M ^a   Kuipers, Ernst J ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; STATIN (PROTEIN);

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL PRACTICE; COLLAGENOUS COLITIS; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG EXPOSURE; DRUG MEGADOSE; DRUG USE; FEMALE; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; LOW DRUG DOSE; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; POPULATION BASED CASE CONTROL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK; TREATMENT DURATION; CASE CONTROL STUDY; CHEMICALLY INDUCED; COLITIS, MICROSCOPIC; MIDDLE AGED; NETHERLANDS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COLITIS, MICROSCOPIC; COLONOSCOPY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PROTON PUMP INHIBITORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84928928129     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.119     Document Type: Article

References (38)

1. Pardi DS, Loftus EV Jr., Smyrk TC et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007 ; 56 : 504-8.
2. Wickbom A, Bohr J, Eriksson S et al. Stable incidence of collagenous colitis and lymphocytic colitis in ?ebro, sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis 2013 ; 19 : 2387-93.
3. Pardi DS. Microscopic colitis: an update. Inflamm Bowel Dis 2004 ; 10 : 860-70.
4. Roth B, Manjer J, Ohlsson B. Microscopic colitis is associated with several concomitant diseases. Drug Target Insights 2013 ; 7 : 19-25.
5. Jobse P, Flens MJ, Loffeld RJ. Collagenous colitis: description of a single centre series of 83 patients. Eur J Intern Med 2009 ; 20 : 499-502.
6. Macaigne G, Lahmek P, Locher C et al. Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol 2014 ; 109 : 1461-70.
7. Fernandez-Banares F, Esteve M, Espinos JC et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007 ; 102 : 324-30.
8. Keszthelyi D, Jansen SV, Schouten GA et al. Proton pump inhibitor use is associated withan increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther 2010 ; 32 : 1124-8.
9. Mahmud T, Scott DL, Bjarnason I. A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis 1996 ; 55 : 211-3.
10. Laine L, Curtis SP, Langman M et al. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology 2008 ; 135 : 1517-25.
11. Maiden L, Th jodleifsson B, Seigal A et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007 ; 5 : 1040-5.
12. Murray LJ, Gabello M, Rudolph DS et al. Transmucosal gastric leak induced by proton pump inhibitors. Dig Dis Sci 2009 ; 54 : 1408-17. & Wilkins: Philadelphia, 1996.
13. Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Rothman KJ, Greenland S, Lash TL eds Modern Epidemiology, 3rd edn, Philidephia. Lippincott Williams & Wilkins, 2008, pp 111-28.
14. Mullin JM, Valenzano MC, Whitby M et al. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther 2008 ; 28 : 1317-25.
15. Burgel N, Bojarski C, Mankertz J et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002 ; 123 : 433-43.
16. Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol 2013 ; 11 : 483-90.
17. Valkhoff VE, Coloma PM, Masclee GM et al. Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk. J Clin Epidemiol 2014 ; 67 : 921-31.
18. Vlug AE, van der Lei J, Mosseveld BM et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999 ; 38 : 339-44.
19. Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fi ft een years of evolution. Fam Pract 1992 ; 9 : 330-9.
20. Solomon SD, McMurray JJ, Pfeffer MA et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005 ; 352 : 1071-80.
21. Masclee GM, Valkhoff VE, van Soest EM et al. Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? Aliment Pharmacol Ther 2013 ; 38 : 178-89.
22. Masclee GM, Valkhoff VE, Coloma PM et al. Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology 2014 ; 147 : 784-92.
23. Coloma PM, Schuemie MJ, Trifi ro G et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 2011 ; 20 : 1-11.
24. Avillach P, Coloma PM, Gini R et al. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. J Am Med Inform Assoc 2013 ; 20 : 184-92.
25. Masclee GM, Coloma PM, Wilde DM et al. Incidences of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and the Netherlands are levelling off. Aliment Pharmacol Ther 2014 ; 39 : 1321-30.
26. Fernandez-Banares F, de Sousa MR, Salas A et al. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis 2013 ; 19 : 411-7.
27. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009 ; 61 : 1454-61.
28. Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol 1985 ; 122 : 495-506.
29. Bonderup OK, Fenger-Gron M, Wigh T et al. Drug exposure and risk of microscopic colitis: a nationwide danish case-control study with 5751 cases. Inflamm Bowel Dis 2014 ; 20 : 1702-7.
30. Al-Ghamdi MY, Malatjalian DA, Veldhuyzen van Zanten S. Causation: recurrent collagenous colitis following repeated use of NSAIDs. Can J Gastroenterol 2002 ; 16 : 861-2.
31. Pascua MF, Kedia P, Weiner MG et al. Microscopic colitis and Medication Use. Clin Med Insights Gastroenterol 2010 ; 2010 : 11-9.
32. Capurso G, Marignani M, Attilia F et al. Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature. Dig Liver Dis 2011 ; 43 : 380-5.
33. Wilcox GM, Mattia AR. Microscopic colitis associated wiThomeprazole and esomeprazole exposure. J Clin Gastroenterol 2009 ; 43 : 551-3.
34. McIntyre AS, Thompson DG, Day S et al. Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway. Gut 1992 ; 33 : 1062-70.
35. Ahluwalia NK, Thompson DG, Barlow J et al. Beta adrenergic modulation of human upper intestinal propulsive forces. Gut 1994 ; 35 : 1356-9.
36. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007 ; 132 : 397-414.
37. MacMahon B, Trichopoulos D. Case-control studies. In: Epidemiology: Principles and Methods. 2nd edn. Lippincott Williams & Wilkins: Philadelphia, 1996.
38. Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Rothman KJ, Greenland S, Lash TL eds Modern Epidemiology, 3rd edn, Philidephia. Lippincott Williams & Wilkins, 2008, pp 111-28.